THC Farmaceuticals changes fiscal year end to December 31, effective Dec 31, 2024

THC Farmaceuticals, Inc.

Board approved fiscal year change from September 30 to December 31 on Dec 31, 2024.
Change aligns reporting cycle with calendar year; no articles or bylaws amendment required.
Company will file a transition report for the short period created by the change.
Filing of this 8-K occurred on January 26, 2026, reflecting the change.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

THC Farmaceuticals, Inc.: Changed fiscal year end from September 30 to December 31, effective December 31, 2024 (effective 2024-12-31).

Change: fiscal year change
Effective: 2024-12-31

Exact text from the filing

On December 31, 2024, the Board of Directors of THC Farmaceuticals, Inc. (the “Company”) approved a change in the Company’s fiscal year end from September 30 to December 31.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001096906-26-000171

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.